HealthEquity, Inc. (HQY) Expected to Announce Earnings of $0.14 Per Share
Wall Street analysts predict that HealthEquity, Inc. (NASDAQ:HQY) will announce earnings per share of $0.14 for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for HealthEquity’s earnings. The highest EPS estimate is $0.15 and the lowest is $0.12. HealthEquity also posted earnings per share of $0.14 in the same quarter last year. The firm is expected to report its next earnings results after the market closes on Tuesday, September 5th.
On average, analysts expect that HealthEquity will report full year earnings of $0.58 per share for the current financial year, with EPS estimates ranging from $0.54 to $0.60. For the next fiscal year, analysts expect that the firm will post earnings of $0.69 per share, with EPS estimates ranging from $0.63 to $0.76. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that follow HealthEquity.
HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.16 by $0.03. The firm had revenue of $55.40 million during the quarter, compared to analysts’ expectations of $54.77 million. HealthEquity had a return on equity of 11.61% and a net margin of 17.04%. HealthEquity’s quarterly revenue was up 25.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.15 EPS.
Several analysts have issued reports on HQY shares. TheStreet upgraded HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. Zacks Investment Research lowered HealthEquity from a “buy” rating to a “hold” rating in a research note on Friday, August 4th. BidaskClub lowered HealthEquity from a “hold” rating to a “sell” rating in a research note on Thursday, August 3rd. Chardan Capital upped their price objective on HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a research note on Wednesday, June 7th. Finally, Cantor Fitzgerald upped their price objective on HealthEquity from $55.00 to $56.00 and gave the company an “overweight” rating in a research note on Wednesday, July 5th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the stock. HealthEquity currently has an average rating of “Buy” and a consensus target price of $50.22.
HealthEquity (NASDAQ HQY) opened at 40.88 on Friday. The stock has a market cap of $2.45 billion, a PE ratio of 76.84 and a beta of 1.73. HealthEquity has a 12-month low of $30.34 and a 12-month high of $54.95. The firm has a 50-day moving average price of $46.96 and a 200-day moving average price of $45.88.
In related news, insider Stephen Neeleman sold 40,000 shares of the stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $48.36, for a total transaction of $1,934,400.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, major shareholder Berkley Capital, Llc sold 248,351 shares of the stock in a transaction that occurred on Tuesday, June 13th. The stock was sold at an average price of $52.80, for a total value of $13,112,932.80. The disclosure for this sale can be found here. Insiders sold 2,458,821 shares of company stock worth $126,120,793 in the last ninety days. 19.00% of the stock is owned by company insiders.
A number of large investors have recently modified their holdings of HQY. Wasatch Advisors Inc. increased its stake in shares of HealthEquity by 2.2% in the second quarter. Wasatch Advisors Inc. now owns 2,442,180 shares of the company’s stock worth $121,694,000 after buying an additional 52,885 shares in the last quarter. Public Employees Retirement System of Ohio increased its stake in shares of HealthEquity by 5.7% in the second quarter. Public Employees Retirement System of Ohio now owns 113,534 shares of the company’s stock worth $5,657,000 after buying an additional 6,095 shares in the last quarter. Amussen Hunsaker & Associates LLC bought a new stake in shares of HealthEquity during the second quarter worth about $11,598,000. 1st Global Advisors Inc. bought a new stake in shares of HealthEquity during the second quarter worth about $213,000. Finally, Piedmont Investment Advisors LLC bought a new stake in shares of HealthEquity during the second quarter worth about $478,000. 91.86% of the stock is currently owned by institutional investors and hedge funds.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.